CRISPR Therapeutics AG

NASDAQ:CRSP

49.59 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 0.5170.5042000701000.0060.0940.1580.17812.3480.329900.2020.2020.1940.1480.0440.15777.016211.9280.3180.3280.1150.5631.0881.35832.3252.3873.5822.7032.3441.5490.7950.4760.247000
Cost of Revenue 56.97651.7992023.42244.63642.1926.82338.85933.92230.646134.91922.46426.94519.94582.36571.00859.3854.19348.76157.24639.53328.8628.80139.8225.63319.51920.0317.84517.1214.80515.57212.0528.6026.0126.1743.7491.4861.164
Gross Profit -56.459-51.295180-23.42225.36457.808-6.817-38.765-33.764-30.468-122.571-22.135873.257-19.743-82.171-70.86-59.336-54.03628.255154.682-39.215-28.532-28.686-39.257-24.545-18.16112.295-15.458-13.538-12.102-13.228-10.503-7.807-5.536-5.927-3.749-1.486-1.164
Gross Profit Ratio -109.205-101.7760.900.3620.578-1,136.167-412.394-213.696-171.169-9.926-67.280.97-97.738-423.562-478.784-1,348.545-344.1780.3670.73-123.318-86.988-249.443-69.728-22.56-13.3730.38-6.476-3.779-4.477-5.643-6.781-9.82-11.63-23.996000
Reseach & Development Expenses 75.3271.33995.14490.698101.55599.935103.555116.622123.223118.245134.47105.321108.27790.56582.36571.00859.3854.19348.76257.24639.53333.82228.80139.8225.63319.51920.0317.84517.1214.80515.57212.0528.6026.0126.1743.7491.4861.164
General & Administrative Expenses 19.48117.95316.47918.29119.03222.3621.16927.00126.27328.02124.12724.35229.80624.51725.76621.53921.35319.5517.27115.51915.76814.92916.54210.17512.7418.83611.3238.1127.7688.64212.0824.1078.7516.1166.2392.4532.1392.572
Selling & Marketing Expenses 00000000000000000000000000000000000000
SG&A 19.48117.95316.47918.29119.03222.3621.16927.00126.27328.02124.12724.35229.80624.51725.76621.53921.35319.5517.27115.51915.76814.92916.54210.17512.7418.83611.3238.1127.7688.64212.0824.1078.7516.1166.2392.4532.1392.572
Other Expenses 26.13924.7219.99720.67118.40612.74211.497.2643.544-0.7622.1971.1010.751.9550.5750.161.4124.23219.5632.9642.3811.125-2.128-0.130.155-0.1260.041-0.071-0.161-0.00678.653-0.0750.08-0.1460.0490.00900
Operating Expenses 94.80189.292110.417108.989120.587122.295124.724143.623149.496145.504158.046129.178137.584114.745107.95592.54780.73373.74366.03372.76555.30148.75145.34349.99538.37428.35531.35325.95724.88823.44727.65416.15917.35312.12812.4136.2022.112.643
Operating Income -151.26-140.58769.583-132.411-95.223-64.487-131.541-182.388-183.26-175.972-145.698-128.849762.618-114.543-107.761-92.399-80.689-73.58610.983139.163-54.983-48.423-45.228-49.432-37.286-26.9970.972-23.57-21.306-20.744-25.31-14.61-16.558-11.652-12.166-6.202-3.625-3.736
Operating Income Ratio -292.573-278.9420.3480-1.36-0.645-21,923.5-1,940.298-1,159.873-988.607-11.799-391.6380.847-567.045-555.469-624.318-1,833.841-468.7010.1430.657-172.903-147.631-393.287-87.801-34.27-19.880.03-9.874-5.948-7.674-10.798-9.432-20.828-24.479-49.255000
Total Other Income Expenses Net 26.13924.7219.99720.67118.40612.74211.497.2643.5440.3632.1971.1010.751.9550.5750.161.4124.23219.563-0.4661.3690.1-2.128-1.142-0.998-1.217-0.412-0.43-0.666-0.45242.807-0.075-0.60611.3360.0490.0090.028-0.071
Income Before Tax -125.121-115.86789.58-111.74-76.817-51.745-120.051-175.124-179.716-175.609-143.501-127.748763.368-112.588-107.186-92.239-79.277-69.35430.546138.697-53.614-48.323-47.356-50.574-38.284-28.2140.56-24-21.972-21.19617.498-14.686-17.164-8.366-12.216-6.201-3.597-3.807
Income Before Tax Ratio -242.014-229.8950.4480-1.097-0.517-20,008.5-1,863.021-1,137.443-986.567-11.621-388.2920.848-557.366-552.505-623.236-1,801.75-441.7450.3970.654-168.597-147.326-411.791-89.829-35.188-20.7760.017-10.054-6.134-7.8427.465-9.481-21.59-17.576-49.457000
Income Tax Expense 1.2870.7240.233-0.4120.9231.32-9.476-0.5756.1183.608-2.253-0.5954.1430.575-0.1470.20.3790.3770.0040.2740.0850.0850.2340.1370.0960.0860.4190.7070.3430.2790.40.008-0.6060.0760.070.1530.0690.285
Net Income -126.408-116.59189.347-112.152-77.74-53.065-110.575-174.549-185.834-179.217-141.248-127.153759.225-113.163-107.039-92.439-79.656-69.73130.542138.423-53.699-48.408-47.59-50.711-38.38-28.30.141-24.707-22.315-21.47517.098-14.694-17.164-8.442-12.286-6.354-3.643-3.237
Net Income Ratio -244.503-231.3310.4470-1.111-0.531-18,429.167-1,856.904-1,176.165-1,006.837-11.439-386.4830.843-560.213-551.747-624.588-1,810.364-444.1460.3970.653-168.865-147.585-413.826-90.073-35.276-20.8390.004-10.351-6.23-7.9457.294-9.486-21.59-17.735-49.741000
EPS -1.49-1.431.12-1.41-0.98-0.67-1.41-2.24-2.4-2.32-1.84-1.6710.01-1.51-1.53-1.32-1.3-1.150.532.52-1.01-0.93-0.92-1.07-0.82-0.620.003-0.62-0.56-0.540.43-0.37-0.43-0.29-0.42-0.22-0.66-0.91
EPS Diluted -1.49-1.431.1-1.41-0.98-0.67-1.41-2.24-2.4-2.32-1.84-1.679.44-1.51-1.53-1.32-1.3-1.150.512.4-1.01-0.93-0.92-1.07-0.82-0.620.003-0.62-0.56-0.540.43-0.37-0.43-0.29-0.42-0.22-0.66-0.91
EBITDA -146.415-135.75474.483-132.411-90.262-64.487-131.541-177.37-183.26-169.933-145.698-123.525766.271-111.828-105.195-92.399-80.689-73.58610.983140.446-53.785-47.611-45.228-48.549-36.421-26.1713.326-23.208-21.266-20.47617.909-14.449-16.993-11.692-12.058-6.153-3.611-3.722
EBITDA Ratio -283.201-269.3530.3720-1.289-0.645-21,923.5-1,886.915-1,159.873-954.68-11.799-375.4560.851-553.604-542.242-624.318-1,833.841-468.7010.1430.663-169.135-145.155-393.287-86.233-33.475-19.2720.103-9.723-5.937-7.5757.64-9.328-21.375-24.563-48.818000